Hyperkalemia and the Use of New Potassium Binders a Single Center Experience from Vestfold Norway (The PotBind Study)

PURPOSE: Hyperkalemia is a common metabolic complication of chronic kidney disease (CKD) and is associated with several serious adverse events. We aimed to treat/prevent hyperkalemia using the new of potassium-binders, allowing maintained renin-angiotensin-aldosterone system inhibitors (RAASi) treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Bjune, Thea, Bøe, Thea Bjerkestrand, Kjellevold, Stig Arne, Heldal, Kristian, Abedini, Sadollah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027611/
https://www.ncbi.nlm.nih.gov/pubmed/36960344
http://dx.doi.org/10.2147/IJNRD.S401623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027611/
https://www.ncbi.nlm.nih.gov/pubmed/36960344
http://dx.doi.org/10.2147/IJNRD.S401623

Ejemplares similares